For: Families and Individuals

Clearer Insights for You and Your Family

Making Genetic Data Understandable

Genetic data can feel overwhelming. Many families receive raw DNA files from consumer testing companies or clinical labs but don’t fully understand what they mean — or how to use them. At Genoxus, we are building a next-generation genetic interpretation platform designed to make complex variant data clearer, more structured, and more insightful.
As an early-stage biotech startup currently developing our Proof of Concept (POC) platform, we are inviting families and individuals to voluntarily submit their VCF (Variant Call Format) files so we can rigorously test and refine our system. In return, participants receive enhanced reports and data insights — at no cost — that may provide new perspectives on their existing genetic results.
Your data will be handled with the highest level of confidentiality and security standards. Participation is completely voluntary.

Relevant Target Groups and Benefits

  • Families who have completed DNA testing through consumer genetic services
  • Individuals with raw VCF files from clinical or research labs
  • Parents seeking deeper understanding of inherited genetic traits
  • Patients exploring second-look interpretation of prior genetic results
  • Health-conscious individuals interested in genomic insights
Key Benefits and Motivations:
  • Better understanding of existing genetic test results
  • Clearer explanation of variants and what they may represent
  • Identification of previously unreported annotations
  • Structured, easy-to-read interpretation reports
  • Confidence that personal genomic data is handled securely

What Genoxus is Offering

  • Zero Cost Participation: During our BETA development phase, participation is free of charge for families and the general public. Please submit your information on this form.
  • Advanced Variant Re-Annotation: We re-analyze your VCF file using updated genomic databases and AI-assisted interpretation models.
  • Expanded Insight Reports: Structured summaries that may include variant classifications, biological context, and supporting research references.
  • Early Access to Innovation: Be among the first to experience our developing platform and help shape its future.
  • Strict Confidentiality: Data is handled with rigorous privacy safeguards and used solely for platform validation and improvement.
We are developing future-focused technology intended to evolve alongside the rapidly advancing field of genomic science, allowing our tools to remain relevant as discoveries and methodologies progress. At the same time, we maintain a participant-centered approach grounded in transparency, informed consent, and responsible data stewardship.
Ultimately, Genoxus is driven by a clear mission: to make complex genomic data more understandable, meaningful, and actionable for everyone — not just specialists.
If you already have a VCF file and are interested in contributing to the future of genomic interpretation while receiving expanded insights into your own data, we invite you to join us. Together, we can help shape the next generation of accessible genomics.
Disclaimer: Genoxus materials, reports, analyses, and platform outputs are provided for research, educational, and informational purposes only. They are not intended to serve as clinical, diagnostic, or medical advice and have not been validated or approved for use in medical decision-making. Any insights or interpretations generated by Genoxus are exploratory in nature and are intended to support research, evaluation, and collaborative learning. These materials should not be used as the sole basis for diagnosis, treatment, patient management, or healthcare decisions. All medical or clinical decisions should be made in consultation with qualified healthcare professionals and supported by appropriately validated clinical testing.

Join Us on the Journey

We collaborate with clinicians, researchers, healthcare organizations, and strategic partners who share our commitment to advancing precision medicine.